Metabolic
syndrome is characterized by systemic insulin resistance that impairs the
ability of insulin to regulate fuel (such as glucose and fat) metabolism.
This syndrome has
become a global epidemic problem with estimates of prevalence
ranging from 20 to 40% in different populations and has been recognized as
a powerful risk factor for the development of cardiovascular disease and type 2
diabetes.
Thus, effectively
fighting this disastrous health problem is a matter of utmost urgency.
No comments:
Post a Comment